Alexion Pharmaceuticals PEG Ratio:
1.560 for May 17, 2013Alexion Pharmaceuticals Historical PEG Ratio Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 1.560 |
| May 16, 2013 | 1.544 |
| May 15, 2013 | 1.595 |
| May 14, 2013 | 1.635 |
| May 13, 2013 | 1.590 |
| May 10, 2013 | 1.579 |
| May 9, 2013 | 1.489 |
| May 8, 2013 | 1.465 |
| May 7, 2013 | 1.461 |
| May 6, 2013 | 1.472 |
| May 3, 2013 | 1.488 |
| May 2, 2013 | 1.459 |
| May 1, 2013 | 1.466 |
| April 30, 2013 | 1.486 |
| April 29, 2013 | 1.496 |
| April 26, 2013 | 1.506 |
| April 25, 2013 | 1.498 |
| April 24, 2013 | 1.353 |
| April 23, 2013 | 1.390 |
| April 22, 2013 | 1.371 |
| April 19, 2013 | 1.404 |
| April 18, 2013 | 1.395 |
| April 17, 2013 | 1.437 |
| April 16, 2013 | 1.459 |
| April 15, 2013 | 1.459 |
| April 12, 2013 | 1.518 |
| April 11, 2013 | 1.522 |
| April 10, 2013 | 1.517 |
| April 9, 2013 | 1.491 |
| April 8, 2013 | 1.489 |
| April 5, 2013 | 1.504 |
| April 4, 2013 | 1.500 |
| April 3, 2013 | 1.475 |
| April 2, 2013 | 1.502 |
| April 1, 2013 | 1.450 |
| March 28, 2013 | 1.810 |
| March 27, 2013 | 1.845 |
| March 26, 2013 | 1.795 |
| March 25, 2013 | 1.814 |
| March 22, 2013 | 1.836 |
| March 21, 2013 | 1.814 |
| March 20, 2013 | 1.844 |
| March 19, 2013 | 1.822 |
| March 18, 2013 | 1.840 |
| March 15, 2013 | 1.840 |
| March 14, 2013 | 1.804 |
| March 13, 2013 | 1.798 |
| March 12, 2013 | 1.802 |
| March 11, 2013 | 1.801 |
| March 8, 2013 | 1.789 |
About PEG Ratio
Click the "Learn More" link below to see how YCharts calculates the PEG Ratio.
The PEG ratio (Price/Earnings To Growth ratio) illustrates the relationship between stock price, earning per share, and the company's growth rate. The PEG ratio consists of the PE ratio divided by the company's growth rate. Using just the PE ratio makes high-growth companies look overvalued relative to others. By dividing the PE ratio by the earnings growth rate, the PEG ratio allows investors to accurately compare companies with different PE ratios and growth rates.
A company with a PEG ratio below 1 is considered undervalued. A company with a PEG ratio around 1 is considered fairly valued. A company with a PEG ratio greater than 1 is considered overvalued.
Learn More
ALXN PEG Ratio Benchmarks
| Companies | |
|---|---|
| Regeneron Pharmaceuticals | |
| Celgene Corporation | 16.06 |
| Athersys |
ALXN PEG Ratio Rankings
| Overall |
83rd percentile 1241 of 7590 |
| Sector |
88th percentile 77 of 651 in Healthcare |
| Industry |
92nd percentile 19 of 238 in Biotechnology |
ALXN PEG Ratio Range, Past 5 Years
| Minimum | 0.0183 | Jan 26 2010 |
| Maximum | 2.648 | Oct 5 2012 |
| Average | 0.8510 |
